🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 114082209 (prev. 114082100 )
- Market Cap
- Micro Cap
- Previous Symbol
- BTX (changed 10/8/2022)
- Previous Name
- Eterna Therapeutics Inc
Business: Ernexa Therapeutics Inc. is a preclinical-stage company focused on using cutting-edge gene-editing tools to deliver highly innovative, effective, and safe off-the-shelf cell therapies for the treatment of advanced solid tumors.
Notes: March 23, 2021 -- NTN Buzztime, Inc. (NYSE American: NTN) today announced that it plans to effect a one for two reverse stock split of its outstanding shares of common stock immediately prior to the closing of the merger with Brooklyn ImmunoTherapeutics LLC, which is anticipated to occur on March 25, 2021. The shares of common stock of the resulting company is expected to commence trading on March 26, 2021 on the NYSE American under the trading symbol “BTX”.
Company Contact
- CEO
- Sanjeev Luther
- CFO
- Andrew Jackson
- Headquarters
- 1035 Cambridge Street, Suite 18A, Cambridge, MA 02141
- Phone
- 617-798-6700
- Investor Relations
- Kirsten Chapman, LHA IR · 415-433-3777 · investors@eternatx.com